Overview
About Adgyl Lifesciences
Adgyl Lifesciences, offers a comprehensive range of in vivo services to support the Discovery, Preclinical and Early to late-stage development of novel molecules with non-clinical IND track and NDA-enabling safety assessment studies for global regulatory registrations. With 30+ years of GLP experience, we ensure data reliability and accuracy with the highest quality and customer satisfaction.
With specialized facilities and a wealth of experience, we offer services for diverse industries - biotech, pharmaceuticals, biologics, medical devices, agrochemicals, cosmetics, nutraceuticals, animal health products, specialty chemicals and industrial chemicals.
Our team has supported 300+ IND/NDA Packages, 600+ Reproduction & Developmental Toxicology studies, and 1000+ Biocompatibility studies. With our strategic partner we support GLP studies in Analytical R&D and ecotoxicology.
Our facility is GLP, AAALAC, OLAW and SAM certified. Our team is well versed with all study guidelines prescribed by international regulatory agencies; including but not limited to US-FDA, OECD, EMA, MHRA, HSA, WHO, DCGI, DBT and CIB of India.
With specialized facilities and a wealth of experience, we offer services for diverse industries - biotech, pharmaceuticals, biologics, medical devices, agrochemicals, cosmetics, nutraceuticals, animal health products, specialty chemicals and industrial chemicals.
Our team has supported 300+ IND/NDA Packages, 600+ Reproduction & Developmental Toxicology studies, and 1000+ Biocompatibility studies. With our strategic partner we support GLP studies in Analytical R&D and ecotoxicology.
Our facility is GLP, AAALAC, OLAW and SAM certified. Our team is well versed with all study guidelines prescribed by international regulatory agencies; including but not limited to US-FDA, OECD, EMA, MHRA, HSA, WHO, DCGI, DBT and CIB of India.